Name
bp1a_am
Label
AM Systolic Blood Presure 1st Measurement
Units
millimeters of mercury
Type
numeric
Tags
Visit (Number) vs AM Systolic Blood Presure 1st Measurement
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Baseline (BL) | - | - | - | - | - | - | 1,516 | 1,516 |
| Clinical Evaluation (CE) | 1,504 | 124.6 | ± 18.7 | 124.0 | -1.0 | 240.0 | 12 | 1,516 |
| Diagnostic Visit (DX) | 1,232 | 123.0 | ± 17.2 | 122.0 | -3.0 | 196.0 | 284 | 1,516 |
| CPAP Titration Visit (CPAP) | 1,056 | 119.3 | ± 25.7 | 122.0 | -3.0 | 194.0 | 460 | 1,516 |
| Two Month Post-CPAP Neurocognitive Visit (2M) | 879 | 122.6 | ± 16.9 | 122.0 | -2.0 | 198.0 | 637 | 1,516 |
| Four Month Post-CPAP Neurocognitive Visit (4M) | 833 | 106.2 | ± 45.7 | 120.0 | -2.0 | 174.0 | 683 | 1,516 |
| Six Month Post-CPAP Neurocognitive Visit (6M) | 851 | 121.6 | ± 16.9 | 122.0 | -2.0 | 196.0 | 665 | 1,516 |
Gender vs AM Systolic Blood Presure 1st Measurement
Baseline (BL)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | - | - | - | - | - | - | 1,516 | 1,516 |
| Male | - | - | - | - | - | - | 958 | 958 |
| Female | - | - | - | - | - | - | 558 | 558 |
Gender vs AM Systolic Blood Presure 1st Measurement
Clinical Evaluation (CE)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,504 | 124.6 | ± 18.7 | 124.0 | -1.0 | 240.0 | 12 | 1,516 |
| Male | 950 | 125.3 | ± 18.7 | 124.0 | -1.0 | 240.0 | 8 | 958 |
| Female | 554 | 123.3 | ± 18.7 | 122.0 | -1.0 | 192.0 | 4 | 558 |
Gender vs AM Systolic Blood Presure 1st Measurement
Diagnostic Visit (DX)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,232 | 123.0 | ± 17.2 | 122.0 | -3.0 | 196.0 | 284 | 1,516 |
| Male | 788 | 123.5 | ± 18.1 | 122.0 | -3.0 | 196.0 | 170 | 958 |
| Female | 444 | 122.0 | ± 15.3 | 120.0 | -1.0 | 178.0 | 114 | 558 |
Gender vs AM Systolic Blood Presure 1st Measurement
CPAP Titration Visit (CPAP)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,056 | 119.3 | ± 25.7 | 122.0 | -3.0 | 194.0 | 460 | 1,516 |
| Male | 693 | 120.5 | ± 25.2 | 122.0 | -3.0 | 194.0 | 265 | 958 |
| Female | 363 | 117.1 | ± 26.6 | 120.0 | -3.0 | 158.0 | 195 | 558 |
Gender vs AM Systolic Blood Presure 1st Measurement
Two Month Post-CPAP Neurocognitive Visit (2M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 879 | 122.6 | ± 16.9 | 122.0 | -2.0 | 198.0 | 637 | 1,516 |
| Male | 572 | 123.2 | ± 16.5 | 122.0 | -2.0 | 198.0 | 386 | 958 |
| Female | 307 | 121.4 | ± 17.5 | 122.0 | -1.0 | 162.0 | 251 | 558 |
Gender vs AM Systolic Blood Presure 1st Measurement
Four Month Post-CPAP Neurocognitive Visit (4M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 833 | 106.2 | ± 45.7 | 120.0 | -2.0 | 174.0 | 683 | 1,516 |
| Male | 541 | 107.2 | ± 45.5 | 122.0 | -2.0 | 174.0 | 417 | 958 |
| Female | 292 | 104.4 | ± 46.1 | 120.0 | -2.0 | 168.0 | 266 | 558 |
Gender vs AM Systolic Blood Presure 1st Measurement
Six Month Post-CPAP Neurocognitive Visit (6M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 851 | 121.6 | ± 16.9 | 122.0 | -2.0 | 196.0 | 665 | 1,516 |
| Male | 552 | 122.6 | ± 16.6 | 122.0 | -1.0 | 196.0 | 406 | 958 |
| Female | 299 | 119.7 | ± 17.3 | 120.0 | -2.0 | 162.0 | 259 | 558 |
Race/Ethnicity vs AM Systolic Blood Presure 1st Measurement
Baseline (BL)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | - | - | - | - | - | - | 1,516 | 1,516 |
| Native American | - | - | - | - | - | - | 28 | 28 |
| Asian | - | - | - | - | - | - | 89 | 89 |
| Black | - | - | - | - | - | - | 172 | 172 |
| Hispanic | - | - | - | - | - | - | 116 | 116 |
| White | - | - | - | - | - | - | 1,102 | 1,102 |
| Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs AM Systolic Blood Presure 1st Measurement
Clinical Evaluation (CE)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,504 | 124.6 | ± 18.7 | 124.0 | -1.0 | 240.0 | 12 | 1,516 |
| Native American | 27 | 126.1 | ± 18.8 | 124.0 | 94.0 | 180.0 | 1 | 28 |
| Asian | 88 | 119.1 | ± 14.8 | 118.0 | 86.0 | 166.0 | 1 | 89 |
| Black | 170 | 126.3 | ± 18.5 | 124.0 | -1.0 | 192.0 | 2 | 172 |
| Hispanic | 114 | 121.9 | ± 19.8 | 120.0 | -1.0 | 174.0 | 2 | 116 |
| White | 1,096 | 125.0 | ± 18.9 | 124.0 | -1.0 | 240.0 | 6 | 1,102 |
| Other | 9 | 126.7 | ± 14.1 | 128.0 | 108.0 | 150.0 | - | 9 |
Race/Ethnicity vs AM Systolic Blood Presure 1st Measurement
Diagnostic Visit (DX)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,232 | 123.0 | ± 17.2 | 122.0 | -3.0 | 196.0 | 284 | 1,516 |
| Native American | 20 | 124.4 | ± 17.6 | 121.0 | 98.0 | 178.0 | 8 | 28 |
| Asian | 74 | 116.3 | ± 18.8 | 118.0 | -1.0 | 154.0 | 15 | 89 |
| Black | 120 | 123.6 | ± 21.4 | 122.0 | -1.0 | 185.0 | 52 | 172 |
| Hispanic | 84 | 122.7 | ± 11.9 | 121.0 | 100.0 | 152.0 | 32 | 116 |
| White | 926 | 123.4 | ± 16.8 | 122.0 | -3.0 | 196.0 | 176 | 1,102 |
| Other | 8 | 125.0 | ± 11.4 | 123.0 | 110.0 | 148.0 | 1 | 9 |
Race/Ethnicity vs AM Systolic Blood Presure 1st Measurement
CPAP Titration Visit (CPAP)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 1,056 | 119.3 | ± 25.7 | 122.0 | -3.0 | 194.0 | 460 | 1,516 |
| Native American | 16 | 121.4 | ± 38.4 | 126.5 | -1.0 | 194.0 | 12 | 28 |
| Asian | 58 | 119.7 | ± 11.2 | 118.0 | 98.0 | 142.0 | 31 | 89 |
| Black | 96 | 118.5 | ± 33.1 | 124.0 | -1.0 | 158.0 | 76 | 172 |
| Hispanic | 73 | 121.2 | ± 18.3 | 122.0 | -1.0 | 158.0 | 43 | 116 |
| White | 808 | 119.1 | ± 25.8 | 122.0 | -3.0 | 190.0 | 294 | 1,102 |
| Other | 5 | 127.6 | ± 18.0 | 128.0 | 112.0 | 156.0 | 4 | 9 |
Race/Ethnicity vs AM Systolic Blood Presure 1st Measurement
Two Month Post-CPAP Neurocognitive Visit (2M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 879 | 122.6 | ± 16.9 | 122.0 | -2.0 | 198.0 | 637 | 1,516 |
| Native American | 13 | 125.0 | ± 26.1 | 114.0 | 98.0 | 192.0 | 15 | 28 |
| Asian | 49 | 118.0 | ± 8.6 | 118.0 | 100.0 | 138.0 | 40 | 89 |
| Black | 77 | 125.0 | ± 24.5 | 126.0 | -1.0 | 198.0 | 95 | 172 |
| Hispanic | 65 | 124.0 | ± 12.2 | 124.0 | 98.0 | 158.0 | 51 | 116 |
| White | 672 | 122.4 | ± 16.4 | 122.0 | -2.0 | 190.0 | 430 | 1,102 |
| Other | 3 | 136.0 | ± 12.2 | 130.0 | 128.0 | 150.0 | 6 | 9 |
Race/Ethnicity vs AM Systolic Blood Presure 1st Measurement
Four Month Post-CPAP Neurocognitive Visit (4M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 833 | 106.2 | ± 45.7 | 120.0 | -2.0 | 174.0 | 683 | 1,516 |
| Native American | 10 | 107.6 | ± 39.2 | 118.0 | -2.0 | 134.0 | 18 | 28 |
| Asian | 47 | 101.0 | ± 41.0 | 114.0 | -2.0 | 138.0 | 42 | 89 |
| Black | 73 | 111.1 | ± 42.3 | 120.0 | -2.0 | 174.0 | 99 | 172 |
| Hispanic | 57 | 112.9 | ± 37.8 | 120.0 | -2.0 | 160.0 | 59 | 116 |
| White | 643 | 105.3 | ± 47.2 | 120.0 | -2.0 | 168.0 | 459 | 1,102 |
| Other | 3 | 130.0 | ± 26.5 | 120.0 | 110.0 | 160.0 | 6 | 9 |
Race/Ethnicity vs AM Systolic Blood Presure 1st Measurement
Six Month Post-CPAP Neurocognitive Visit (6M)
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 851 | 121.6 | ± 16.9 | 122.0 | -2.0 | 196.0 | 665 | 1,516 |
| Native American | 13 | 121.9 | ± 10.5 | 124.0 | 104.0 | 138.0 | 15 | 28 |
| Asian | 50 | 117.6 | ± 9.6 | 119.0 | 100.0 | 138.0 | 39 | 89 |
| Black | 75 | 127.3 | ± 13.4 | 124.0 | 105.0 | 196.0 | 97 | 172 |
| Hispanic | 61 | 119.2 | ± 19.2 | 120.0 | -1.0 | 146.0 | 55 | 116 |
| White | 649 | 121.4 | ± 17.4 | 122.0 | -2.0 | 162.0 | 453 | 1,102 |
| Other | 3 | 132.7 | ± 20.2 | 122.0 | 120.0 | 156.0 | 6 | 9 |